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a  b  s  t  r  a  c  t
The skull base is a highly complex and difficult to access anatomical region, which consti-
tutes  a relatively common site for neoplasms. Imaging plays a central role in establishing
the  differential diagnosis, to determine the anatomic tumour spread and for operative plan-
ning.  All skull base imaging should be performed using thin-section multiplanar imaging,
whereby CT and MRI can be considered complimentary. An interdisciplinary team approach
is  central to improve the outcome of these challenging tumours.





2.  Technical  considerations1.  Background
The skull base is a highly challenging anatomical region with
regards to imaging diagnosis and intervention. Interposed
between the cranial contents, face and neck, it is difficult
to access, but constitutes a relatively common site for neo-
plasms. With densely packed neural structures and vessels
traversing multiple tissue layers, there is limited tolerance
to manipulation or mass effect. The blood supply to the
skull base is dual via the extracranial and intracranial cir-
culation, which has implications for disease propagation and
endovascular therapy. Numerous foraminal openings further
complicate the anatomy and provide a conduit for tumour
spread into the deep spaces of the head and neck. Rather than
a uniform entity, the skull base represents a complex, mul-
ticompartmental network of tissues. Not surprisingly, there
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1507-1367/© 2016 Greater Poland Cancer Centre. Published by Elsevier is no definitive system for the categorisation of skull base
tumours. The main purpose of this review is to guide the radio-
logical differential diagnosis. Benign and malignant skull base
lesions frequently arise in a typical location, whereas their
imaging features may overlap. Importantly, the clinical pre-
sentation and deficit usually depend more  on the tumour site
than histology. For these reasons, the authors have chosen a
subdivision of neoplasms according to their anatomical loca-
tion. The upcoming sections will discuss anterior, central and
posterior skull base tumours, with neoplasms of the petrous
temporal region included in the latter section.Owing to its undulating course and varying thickness, all
skull base imaging should be performed using thin-sections
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n at least two planes, whereby most authors consider CT and
RI  complimentary.1 CT is extremely useful in delineating
one detail and identifying aggressive features of malignancy,
articularly erosion. We  recommend a CT slice thickness of
.5–1 mm with a bone algorithm reconstruction including
ultiplanar reformats. The choice of a small field of view
an be helpful to maximise the signal to noise ratio in small
tructures, for example to delineate the bony labyrinth. Where
vailable, the use of a high field strength (3 T) should be
onsidered, as this produces increased image  signal for the
esolution of lesion detail and to identify perineural disease.2,3
RI  sequences may vary between institutions, but a typical
kull base MRI  protocol includes T1, T2 and post Gadolin-
um contrast T1 sequences at a slice thickness ≤3 mm.  High
esolution T2 CISS (constructive interference in steady state)
maging improves the accurate visualisation of the cranial
erves, particularly in the basal cisterns and internal audi-
ory meatus, in which the nerves stand out from surrounding
SF. Thin-section post Gadolinium T1 imaging is the most sen-
itive technique to demonstrate perineural tumour spread,
resence of which usually worsens the prognosis and may
reclude cure if unrecognised.4,5 Diffusion-weighted imaging
t the skull base remains technically challenging due to arte-
act and distortion from the bone air interface, which can be
educed by employing a non-echoplanar sequence. Although
eliable threshold values are difficult to define, malignant
umours tend to display lower diffusivity than benign disease
ith the exception of certain non-neoplastic lesions such as
pidermoid cysts and cholesteatoma, which are known for
heir characteristic diffusion restriction.6 Bone marrow inva-
ion may be evident on unenhanced T1 images or STIR (short
au inversion recovery), which can also unmask metastatic
ymph node involvement. Post Gadolinium imaging generally
ids the delineation of solid tumours including differentia-
ion of peripherally enhancing inflammatory sinus disease
rom tumour. Some controversy exists regarding the value of
at-suppressed post contrast imaging of the skull base due
o a potential risk of artefact from incomplete fat suppres-
ion being mistaken for enhancing tumour.7 Time-of-flight MR
ngiography (TOF-MRA) is a flow imaging technique, which
ives information about the patency and position of the cra-
ial arteries in relation to tumour. This has relevance for
urgical planning, although MRA  may not accurately depict
lood supply for all lesions. Therefore digital subtraction
ngiography (DSA) retains an important role in delineating the
rterial supply of hypervascular tumours, particularly in can-
idates for embolisation treatment. This may be performed
ither as an adjunct prior to radical surgery or as a palliative
easure where curative resection is not possible.8 Recently
ET/CT, specifically 18-F Fluorothymodine imaging, has been
uggested as potentially beneficial in head and neck cancer
taging.9
.  The  role  of  imagings the imaging features of some skull base tumours overlap,
adiologists may appropriately refrain from giving a defini-
ive tissue diagnosis.10 It is however important to accurately
escribe the anatomic spread of the tumour and identifytherapy 2 1 ( 2 0 1 6 ) 304–318 305
the structures involved as this will determine the lesion
resectability and would help planning the optimal and safest
route for biopsy. For example, invasion of vascular structures
such as the ICA or cavernous sinus could preclude radical
resection. Imaging evidence of tumour hypervascularity may
alter the differential diagnosis and increases the biopsy risk.
Orbital and optic nerve involvement may prevent curative
surgery, especially if bilateral.1 Meningeal spread and brain
invasion, as well as extension to surgically less accessible sites
such as the paranasal sinuses or the prevertebral space should
always be assessed for. Specialist centre referral onto an estab-
lished multidisciplinary pathway represents internationally
accepted best practice for patients with complex skull base
lesions.
4.  Anterior  skull  base
4.1.  Anatomical  boundaries
The anterior skull base separates the cranial contents from
the paranasal sinuses and orbits. It extends from the poste-
rior wall of the frontal sinuses to the anterior clinoid processes
and lesser sphenoid wing. Laterally, it is bound by the orbital
plates of the frontal bone. In its centre, it contains the crib-
riform plate of the ethmoid bone, a thin osseous layer which
is susceptible to damage. The upcoming section will focus on
olfactory groove, sinonasal neoplasms and the orbits.
4.2.  Anterior  skull  base  tumours
4.2.1.  Olfactory  groove
The olfactory groove is a paired furrow in the cribriform
plate on either side of the crista galli. It transmits the olfac-
tory nerves and anteriorly contains a small foramen for the
nasociliary nerve, a branch of the ophthalmic nerve (V1).
4.2.1.1.  Meningioma.  Meningioma commonly arises in the
olfactory groove, though this tumour may occur anywhere
along the skull base. Other typical sites include the planum
sphenoidale, parasellar region, clivus and tentorium cerebelli.
Meningiomas represent 13–26% of all intracranial masses with
a female to male ratio of 2:1 and most often occur beyond the
5th decade.11–14 On CT, meningiomas may show associated
hyperostosis as a supportive finding and approximately 75%
appear hyperattenuating to brain. Classic MRI  appearances
are those of a T1 and T2 isointense lesion with avid contrast
enhancement and an enhancing dural “tail”, but this is not a
necessary or pathognomonic feature (Fig. 1a and b). Depending
on their size and location, these lesions may be surprisingly
indolent, but certain features such as progressive optic nerve
compromise can require emergency intervention.14
4.2.1.2.  Olfactory  neuroblastoma.  Olfactory neuroblastoma
(synonym esthesioneuroblastoma) is a neuroendocrine
tumour arising from the olfactory mucosa. The incidence
of this aggressive neoplasm peaks in the second and sixth
decade, although it can occur at any age.15 Soft tissue in the
olfactory niche, which could be confused with a small menin-
gioma or sinus disease, may be the earliest imaging evidence
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Fig. 1 – (a) and (b) Coronal and sagittal post Gadolinium T1
images demonstrating an olfactory groove meningioma
with a dural tail (arrow). (c) Large right spheno-orbital
mengioma in a different patient with proptosis, optic nerve
compression and intracranial extension. Note the
hyperostotic expansion of the adjacent sphenoid wing
(arrow).
Fig. 2 – Coronal post Gadolinium T1 images in two different
patients demonstrating subtle enhancing tissue in the right
olfactory groove (a, white arrow) and an extensive
destructive lesion (b) involving the anterior skull base and
paranasal sinuses with evidence of prior surgery. In both
patients, the proven histological diagnosis was olfactory
neuroblastoma. Patient (a) also has an incidental mucus
retention cyst in the left maxillary antrum (black arrow)
characterised by minimal rim enhancement.(Fig. 2a). Olfactory neuroblastoma frequently spreads to the
ipsilateral maxillary and ethmoid sinuses; meningeal and
olfactory bulb invasion is common in advanced tumours
(Fig. 2b). On MRI, olfactory neuroblastomas usually show
intermediate T1 signal and mild T2 hyperintensity with avid
homogenous enhancement due to hypervascularity. Small
peripheral cysts and calcification have been reported as
characteristic features, but may be absent.16 On CT, bone
destruction may disclose the malignant nature of olfactory
neuroblastoma and represents a distinguishing feature from
meningioma.
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Fig. 3 – Not a tumour: Sagittal T2 image demonstrating a
mass within an anterior skull base defect. This sincipital
encephalocele could be mistaken for a tumour, unless the


































Fig. 4 – Axial T1 image: Avidly enhancing juvenile
angiofibroma presenting as a posterior nasal space mass
with extension into the right pterygopalatine fossa,f Dr K. Mankad, Great Ormond Street Hospital, London.)
.2.2.  Sinonasal  region
ituated immediately below the osseous anterior skull base,
he sinonasal space represents a common primary site for
enign and malignant neoplasms. The cribriform plate, which
orms the roof of the nasal cavity, provides relatively little
esistance to spreading cancers.
.2.2.1.  Benign  sinonasal  masses.
4.2.2.1.1.  Benign  sinonasal  masses.  Benign sinonasal
asses consist of polyps, inflammatory mucosal disease,
aemangiomas and inverted papillomas, whereby polyps rep-
esent the vast majority (approximately 70%).17 Benign lesions
ay require resection if causing obstructive symptoms, but do
ot usually invade the skull base. A sincipital encephalocele is
 congenital malformation, which may on first glance mimic
n anterior skull base tumour, but the presence of herniating
rain tissue (Fig. 3) should alert to the correct diagnosis.
4.2.2.1.2.  Juvenile  angiofibroma.  This tumour arises in
he posterior nasal space from primitive vascular tissue at
he sphenopalatine foramen. It occurs in adolescence and
s noteworthy because of its relatively characteristic appear-
nces and high bleeding risk on biopsy. The typical imaging
nding is that of a T1 hypointense and T2 intermediate sig-
al lesion exhibiting avid enhancement with internal flow
oids and extension into the pterygopalatine fossa (Fig. 4) as
 hallmark sign. These features, together with the patient’s
ge, can help in differentiating juvenile angiofibromas from
ther nasopharyngeal lesions.18 Juvenile angiofibromas may
estroy surrounding bone and invade the skull base or orbit.
SA accurately demonstrates the vascular supply of these
eoplasms, which most commonly originates from distalnternal maxillary artery (IMA) branches, particularly the
phenopalatine, descending palatine, and posterior superior
lveolar branches. Blood supply may also be present via the
scending pharyngeal artery. Presurgical embolisation shouldsphenoid sinus and masticator space.
be considered for these hypervascular tumours to reduce the
surgical risk and blood loss. Despite their benign histology,
JNA are locally aggressive and tend to recur if not completely
resected.
4.2.2.2.  Sinonasal  malignancy.  Imaging is unreliable in the dif-
ferentiation of sinonasal cancer subtypes, but is essential for
the identification of malignant features and for disease stag-
ing. Bone invasion constitutes a suspicious sign, which may
manifest as lysis on CT or loss of the normal bone low sig-
nal rim on T1 MRI. Sinonasal tumours can easily spread along
the lamina papyracea into the orbit and via the cranial nerves
into the central skull base.10 Solid enhancement distinguishes
these tumours from retained secretions (Fig. 5) and mucosal
inflammation with the caveat that large tumours can show
central necrosis.
4.2.2.2.1.  Squamous  cell  carcinoma.  Squamous cell carci-
noma (SCC) is the most common malignancy of the paranasal
sinuses, typically affecting men  over the age of 50 years.15
SCCs account for 80% of sinonasal malignant tumours with
25–58% in the maxillary sinus, 25–35% in the nasal cavity, 10%
in the ethmoid air cells and 1% in the frontal sinus.19 Known
risk factors include exposure to Nickel, wood dust, a num-
ber of chemicals, alcohol and tobacco. The imaging features
of sinonasal SCC are non-specific, however, the presence of
unilateral sinus disease, especially if associated with a large
soft tissue mass and necrosis should raise concern.20 As CT
may be first test performed for ongoing rhinosinusitis, identi-
fication of bone invasion becomes particularly important. SCC
may exhibit intermediate to low T2 signal as a hallmark of cel-
lularity, which together with solid enhancement represents a
distinguishing feature from benign mucosal disease. Metic-
ulous staging is very important, because synchronous head
and neck cancers or pulmonary malignancy may be present
in approximately 15% of patients.
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Fig. 5 – (a) and (b) Axial and coronal post Gadolinium T1
images showing a SCC centred on the left sided nasal space
with invasion of the ethmoid air cells, orbit and secondary
obstruction of the left maxillary antrum (non-enhancing
Fig. 6 – (a) and (b) Axial CT and post Gadolinium coronal T1
images featuring a destructive frontoethmoidal tumour
with a histological diagnosis of adenocarcinoma.secretions, arrow).
4.2.2.2.2.  Adenoid  cystic  carcinoma.  Adenoid cystic car-
cinoma is a slow growing but highly aggressive malignancy
with the highest local recurrence rate of all sinonasal tumours
(75–90%).20 Perineural spread represents a hallmark feature of
these neoplasms, which may account for their characteristic
delayed recurrence after up to 20 years (for more  informa-
tion on perineural spread see Section 5.2.2.1). Adenoid cystic
carcinomas are usually of intermediate T2 signal, but low
grade lesions can mimic  inflammatory disease by exhibiting
T2 hyperintensity.
4.2.2.2.3.  Adenocarcinoma.  Adenocarcinoma (Fig. 6) rep-
resents around 10% of nasal cavity malignant tumours. Similar
to SCC, a particular association has been reported between
tumour incidence and toxic exposure the hardwood and shoe
industry.21
4.2.2.2.4.  Sinonasal  undifferentiated  carcinoma.
Sinonasal undifferentiated carcinoma is a particularlyaggressive malignant tumour, often diagnosed in an advanced
stage involving the orbit, paranasal sinuses and anterior
cranial fossa.19
4.2.2.2.5.  Mucoepidermoid  carcinoma.  Mucoepidermoid
carcinoma, although more  common in the parotid gland,
may arise from minor salivary glands of the hard palate and
typically exhibits T1 shortening on MRI due to proteinaceous
content.
4.2.2.2.6.  Sarcoma.  Approximately 15–20% of head and
neck sarcoma occurs in a sinonasal distribution and is
morphologically indistinguishable from the carcinomatous
malignancies.
4.2.2.2.7.  Sinonasal  melanoma.  Sinonasal melanoma is
the commonest mucosal melanoma, although overall it only
accounts for 2.5% of all melanomas.21 Melanomas often arise
from the nasal septum or turbinate remodelling bone in a
deceivingly benign manner, although erosion occurs even-
tually (Fig. 7).9 These neoplasms may show intrinsic T1
shortening due to its melanin content and enhance with con-
trast. Desmoplastic melanoma has a striking propensity to
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Fig. 7 – (a) Axial CT featuring right sided nasal mucosal
thickening with subtle erosion of the middle turbinate. (b)
Axial post Gadolinium T1 image obtained 9 months later
demonstrating a destructive lesion involving the nasal
mucosa and both maxillary antra. The diagnosis in this


















Fig. 8 – (a) Coronal CT showing nasal lymphoma with bone
destruction and (b) coronal post Gadolinium T1 image in a
different patient demonstrating sinonasal lymphoma
spreading to the central skull base.nvade nerves, presumably due to high expression of the p75
eurotropic receptor, which is also found in a proportion of
denoid cystic carcinoma.15
4.2.2.2.8.  Non-hodgkins  lymphomas.  Non-hodgkins lym-
homas represent approximately 5% of head and neck
alignancies and may involve almost any site in this region.22
mong sinonasal lymphomas, lesions arising from the nasal
eptum or Waldeyer’s lymphatic ring are relatively common.19
arly imaging signs may be confined to non-specific mucosal
hickening, with subsequent florid bone destruction (Fig. 8a).
n immunocompetent patients with no predisposing factors,
he diagnosis is often delayed owing to the relative rarity
f the disease and its lack of pathognomic appearances.
inonasal lymphoma tends to exhibit intermediate signal
ntensity on all sequences, although T2 hyperintensity is also
ecognised.20 B-cell lymphoma typically presents as a large
oft tissue mass, which is commonly associated with bone
emodelling although bone destruction also occurs. On thecontrary, T-cell lymphoma may result in bone destruction
in excess of the soft tissue mass.20 Diffusion restriction is
a known feature of lymphoma and a marker of its relative
cellularity. Accompanying fever and weight loss in addition
to local signs such as nasal obstruction and epistaxis could
prompt suspicion, but are hardly specific. Primary lymphoma
of the osseous skull base is distinctly uncommon; however,
sinonasal lymphoma may invade the anterior skull base
directly or reach the central skull base via perineural spread
(Fig. 8b).
4.2.3.  Orbital  region
Due to their close proximity, anterior skull base lesions may
involve the orbits, and vice versa. The roof of the orbit forms
the floor of the frontal sinus and part of the anterior cranial
fossa. Medially, each orbit is separated from the ethmoid air
d rad310  reports of practical oncology an
cells by the lamina papyracea. The orbital apex forms the tran-
sition to the central skull base.
4.2.3.1.  Skull  base  lesions  with  orbital  invasion.  If sufficiently
large, any tumour of the anterior and central skull base may
spread to the orbits. Aggressive neoplasms such as olfactory
neuroblastoma and malignant sinonasal tumours have the
destructive potential to invade the orbit, especially via the
thin lamina papyracea. In a relevant clinical context, the pres-
ence of visual symptoms or ophthalmoplegia should prompt
urgent imaging. CT imaging provides a good natural contrast
between bone, fat, muscles and vitreous, whereby bone ero-
sion and loss of normal fat planes can be subtle markers of
involvement. Orbit targeted MRI  sequences (e.g. coronal STIR,
axial and coronal pre and post contrast T1 imaging at a slice
thickness of 3 mm)  can be helpful to depict orbital invasion.
A common skull base lesion to spread via the orbital apex
towards the globe is meningioma (Fig. 1c), but these lesions
can also arise within the orbit itself from the optic nerve dural
layer.
4.2.3.2.  Orbital  tumours  with  spread  to  the  skull  base.  Intracra-
nial extension of an optic nerve sheath meningioma or
optic nerve glioma are both well demonstrated on imaging
and can be distinguished by the presence of nerve sheath
enhancement versus an intrinsic optic nerve mass. Skull base
dissemination including perineural spread may be encoun-
tered in malignant orbital neoplasms such as metastatic
disease (especially breast and lung), lymphoma and uveal
melanoma.23 There are no pathognomonic features, but if
the epicentre of the tumour is clearly located within the
orbit, this can help to narrow the differential diagnosis. Cer-
tain benign lesions such as cavernous haemangioma less
commonly extend beyond the orbital borders. Nerve sheath
tumours, particularly ophthalmic nerve Schwannoma may
rarely be encountered at the roof of the orbit bordering the
anterior cranial fossa. Benign lacrimal gland lesions can erode
the roof of the orbit, the most common being pleomorphic
adenoma.10
5.  Central  skull  base
5.1.  Anatomical  boundaries
The central skull base extends from the anterior clinoid pro-
cesses and lesser wing of the sphenoid to the petrous ridge and
temporal bones, incorporating the middle cranial fossa later-
ally on each side. In its centre, it contains the sella turcica
and part of the clivus. The spheno-occipital synchondrosis
marks the posterior border of the central skull base medially
and the petroclival synchondrosis laterally. The central skull
base contains a large number of important structures includ-
ing the ICA, cavernous sinus, optic canal, superior orbital
fissure, the foramina rotundum, ovale and spinosum and the
vidian canal. The upcoming section will focus on tumours
of the sella, the parasellar region and the clivus including
osseous neoplasms of the central skull base in the latter
section.iotherapy 2 1 ( 2 0 1 6 ) 304–318
5.2.  Central  skull  base  tumours
5.2.1.  Sella  turcica
The sella turcica forms part of the sphenoid body contain-
ing the pituitary gland in its central hypophyseal fossa. The
anterior border of the sella is defined by the tuberculum sellae
and its posterior border by the dorsum sellae and posterior
clinoid processes. Tumours in this region include pituitary
microadenoma and macroadenoma, meningioma and cran-
iopharyngioma.
5.2.1.1.  Pituitary  microadenoma.  Pituitary microadenoma
(<1 cm)  may be discovered incidentally or through excess hor-
mone production with prolactinoma being the commonest.
Small lesions are best depicted by MRI, which typically
demonstrates low T1 and increased T2 signal with reduced
Gadolinium enhancement compared to the remainder of the
gland (Fig. 9a). Dynamic post contrast imaging can improve
the visualisation of altered contrast uptake in microade-
nomas, where this is not appreciable on conventional post
Gadolinium sequences. A typical indication for dynamic
imaging would be following a normal or inconclusive conven-
tional pituitary MRI in a patient with proven excess serum
hormone levels.
5.2.1.2.  Pituitary  macroadenoma.  Pituitary macroadenoma
(>1 cm)  often extend into the suprasellar compartment, clas-
sically giving rise to a “snowman” or “Fig. 8” morphology
(Fig. 9b), potentially compressing the optic nerve and/or the
optic chiasm. Pituitary adenomas invade the cavernous sinus
in 6–10% of cases, often unilaterally, thereby limiting surgi-
cal resectability.24 Unlike meningiomas, pituitary adenomas
rarely narrow the cavernous carotid artery.25 Occasionally,
pituitary adenomas can grow inferiorly eroding the sella floor
or arising in an exclusively intraosseous location in which case
an empty sella appearance maybe the relevant imaging clue.
5.2.1.3.  Craniopharyngioma.  Craniopharyngioma is a tumour
arising in the suprasellar midline from remnants of Rathke’s
pouch, though it can occur anywhere from the hypothalamus
to the nasopharynx. Typical imaging features are calcifications
and a cystic-solid appearance with T1 signal shortening due
to proteinaceous content (Fig. 10).26
5.2.1.4.  Other  suprasellar  tumours.  Other suprasellar tumours
include germinoma, glioma and hamartoma, which originate
from brain parenchyma as opposed to the skull base.
5.2.2.  Parasellar  tissues  and  neural  foramina
Immediately bordering the sella laterally on each side is the
cavernous sinus, containing the cavernous segment of the ICA
(internal carotid artery) and from superior to inferior the tran-
siting cranial nerves III, IV, VI, V1 and V2. Anterior to the
sella is the optic canal and superior orbital fissure; infero-
laterally is the greater sphenoid wing containing the vidian
canal (for the Vidian nerve), the foramina rotundum (maxillary
nerve, V2), ovale (mandibular nerve, V3) and spinosum (middle
meningeal artery, vein and nerve). Through these apertures,
tumours originating outside the cranial cavity invade the cen-
tral skull base. In the following section, perineural spread,
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Fig. 9 – (a) Coronal post Gadolinium T1 image
demonstrating a pituitary microadenoma (arrow). (b)
Pituitary macroadenoma with suprasellar extension and















Fig. 10 – (a) and (b) Sagittal pre and post Gadolinium T1
images demonstrating a cystic-solid craniopharyngioma
with intrinsic T1 shortening and heterogeneous
(in up to 28%), melanoma, lymphoma and sarcoma.28he medial surface of the right cavernous ICA.
eningiomas and schwannomas of the parasellar region will
e reviewed.
.2.2.1.  Perineural  spread.  Perineural spread (PNS) represents
n insidious and feared form of metastatic disease, which may
ropagate along any nerve, most commonly via the trigemi-
al branches V2 and V3 (Fig. 10) into the central skull base.
NS also commonly affects the descending branch of the facial
erve in face and neck cancers. Although the presence of PNS
orsens the prognosis, cure may still be achievable, but this
epends on accurate estimation of the disease extent. On post
adolinium imaging, PNS manifests as nerve thickening and
athological, sometimes nodular, enhancement, which can be
ubtle and is easily missed unless specifically searched for.enhancement.
Loss of normal CSF signal within Meckel’s cave also represents
a suspicious feature. It should be emphasised here, that nor-
mal  structures (e.g. venous plexus), can give rise to perineural
enhancement, hence enhancement as such does not equate to
malignant invasion.27 Multiplanar reconstructions, side com-
parison and a review alongside normal studies are useful
especially in challenging cases. Clinical symptoms of PNS are
often vague including neuropathic pain or dysaesthesia, how-
ever, close to 50% of patients remain asymptomatic.26 Due to
its high incidence, squamous cell carcinoma is the most com-
mon  neoplasm spreading along cranial nerves.10 Sinonasal
PNS is commonly associated with adenoid cystic carcinoma5.2.2.2.  Meningioma.  Meningioma is especially common in
the parasellar region, whereby “en plaque” lesions can be
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Fig. 11 – Coronal post Gadolinium T1 image showing SCC
perineural spread along the left mandibular nerve (V3)
characterised by nerve thickening with avid perineural
Fig. 12 – (a) and (b) Axial T2-weighted and coronal
T1-weighted image through Meckel’s cave featuring a
content (Fig. 13).19 Common primary sites include lung, breast,enhancement.
missed if small and are difficult to completely resect. For
lesions in proximity to the cavernous sinus, narrowing of the
cavernous ICA is commonly seen with meningioma.
5.2.2.3.  Schwannoma.  Schwannoma may occur in the central
skull base, most frequently involving the trigeminal nerve (V)
(Fig. 11). The most common type of schwannoma is vestibular
schwannoma, which will be discussed in Section 6.2.3.1.
5.2.3.  Clivus  and  osseous  central  skull  base
The clivus represents a bone slope composed of sphenoid
bone superiorly and occipital bone inferiorly with the spheno-
occipital synchondrosis joining the two and marking the
border to the posterior skull base. Neighbouring structures of
the clivus are the ICA within the foramen lacerum laterally,
the basilar artery and pons dorsal to the clivus surface. This
section will discuss chordoma, chondrosarcoma, bone metas-
tases and osteosarcoma.
5.2.3.1.  Chordoma.  Chordoma is a histologically benign but
locally invasive neoplasm arising from embryonic remnants
of the primitive notochord. Chordomas present as expansile
clival tumours, often exhibiting an aggressive pattern of bone
destruction with replacement of the clivus bone marrow and
erosion of its cortical margins.29 On MRI, they are typically T1
isointense to hypointense and T2 isointense to hyperintense
lobulated masses (Fig. 12) showing heterogenous Gadolinium
enhancement. In approximately 25–40%, chordomas destroy
the clivus and spread to the middle or posterior cranial fossa.
Chordomas occur in adulthood at any age, often presenting
with headache and cranial nerve palsies. Local recurrence is
common with an overall 5 year survival rate of 60%, however,
distant metastases are unusual.305.2.3.2.  Chondrosarcomas.  Chondrosarcomas are rare
tumours representing approximately 6% of all skull basetrigeminal Schwannoma.
lesions. The head and neck represents a relatively com-
mon primary site contributing 10% of all chondrosarcomas
with a predilection for the central skull base.20,31 Chon-
drosarcomas tend to occur towards the sixth decade and
are uncommon below 40 years of age. The degree of bone
destruction increases with tumour grade, whereby well dif-
ferentiated tumours more  often exhibit a classic chondroid
matrix, characterised by punctuate or curvilinear miner-
alisation on CT (Fig. 12). Typical MRI appearances are low
T1, high T2 signal with relatively avid contrast enhance-
ment. The imaging features of chondrosarcoma often
overlap with those of chordoma, making a biopsy necessary
unless the clivus is clearly spared, which only happens in
chondrosarcoma.
5.2.3.3.  Metastases.  Metastases are the most common neo-
plasm affecting the osseous skull base.1 Even tough they may
occur anywhere, the clivus, petrous apex and sphenoid trian-
gle are most frequently affected due to their increased marrowkidney and prostate, whereby im2aging evidence of multifo-
cal disease and a relevant past medical history can be useful
diagnostic indicators.
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Fig. 14 – (a)–(c) Axial CT, axial T2 and sagittal post
Gadolinium T1 image showing chondroid matrix, T2mage demonstrating a well-defined clival chordoma.
.2.3.4.  Osteosarcoma.  Osteosarcoma is a very rare tumour
f the skull base with an estimated 100 cases of reported
o date.31 These neoplasms occur with an age peak in the
hird decade, slightly later than long-bone osteosarcoma. Risk
actors for secondary osteosarcoma include Paget’s disease,
i Fraumeni syndrome and fibrous dysplasia. Osteosarcoma
ay occur following cranial radiotherapy in the periphery
f the radiation field, very commonly in the jaw presenting
ith dental pain and loose teeth.31 On CT, osteosarcoma may
emonstrate a mixture of lysis and sclerosis (Fig. 14a) with
loudy or clustered mineralisation.26,32 When present, a Cod-
an  triangle or “sunburst” pattern of periosteal reaction is
haracteristic. Depending on mineral content, osteosarcoma
ay return variable MR  signal, most commonly low T1 and
ntermediate T2 signal. These lesions tend to enhance less
vidly than chondrosarcoma..2.3.5.  Fibrous  dysplasia.  An important non-neoplastic bone
ondition, which may affect the skull base is fibrous dyspla-
ia. FD is caused by an activating mutation in the GNAS genehyperintensity and heterogenous enhancement within a
chondrosarcoma.
and can occur within a single bone (‘monostotic’ FD) or involve
multiple sites (‘polyostotic’ FD), with the most severe form of
polyostotic FD occurring in the McCune-Albright syndrome.
This expansile bone disease could on first glance mimic  a
malignant tumour, but does not show aggressive features
d radiotherapy 2 1 ( 2 0 1 6 ) 304–318
Fig. 15 – (a) Axial unenhanced T1 image demonstrating
loss of the normal skull base bone marrow signal (arrows),
which was subsequently proven to represent metastatic
infiltration from breast cancer. (b) Normal appearances (N)
for comparison.314  reports of practical oncology an
or growth. On CT, fibrous dysplasia exhibits a characteristic
ground-glass like fibrous matrix (Fig. 14b), sometimes mixed
with areas of sclerosis and lucency and a variably defined
border to surrounding normal bone. On MRI, fibrous dyspla-
sia typically returns reduced T1 and T2 signal. Whilst the
condition is entirely benign, it should be remembered that
secondary osteosarcoma can arise on a background of long-
standing fibrous dysplasia.
6.  Posterior  skull  base
6.1.  Anatomical  boundaries
Centrally, the posterior skull base extends from the spheno-
occipital synchondrosis to the occipital inner table and
laterally from the petrous ridge to the temporal and occipi-
tal inner table. Important apertures of the posterior skull base
are the internal auditory meatus, jugular foramen, hypoglos-
sal canal and foramen magnum.  In the upcoming sections,
tumours of the petrous temporal region, cerebellopontine
angle, vestibular aqueduct and foramen magnum will be dis-
cussed.
6.2.  Posterior  skull  base  tumours
6.2.1.  Petrous  temporal  region
The petrous ridge marks the anatomical border between the
middle and posterior cranial fossa, but tumours do not respect
this division and can involve either compartment or both.
6.2.1.1.  Glomus  tympanicum.  Glomus tympanicum is the
most common middle ear neoplasm second only to vestibular
schwannoma.34 These lesions may occur at any age, but are
most common between 40 and 70 years. Glomus tumours are
paragangliomas consisting of chromaffin cells separated by
vascular channels, giving rise to their characteristic “salt and
pepper” appearance on MR  imaging caused by a combina-
tion of avid enhancement and low signal flow voids. When
assessing glomus tumours, it is useful to combine CT imag-
ing to delineate petrous bone detail and thin-section MRI,
which is superior at identifying soft tissue enhancement. Glo-
mus typanicum classically arises at the cochlear promontory
(Fig. 14) manifesting on otoscopy as a small red mass within
the anterior inferior quadrant of the tympanic membrane.
Alternative locations along the medial wall of the middle ear
cavity may be encountered, along the tympanic branch of the
glossopharyngeal nerve (IX, Jacobson’s nerve) and the auricu-
lar branch of the vagus nerve (X, Arnold’s nerve).34 The typical
clinical presentation is with pulsatile tinnitus, although this
is not a specific symptom.
6.2.1.2.  Glomus  jugulare.  Glomus jugulare arises from glo-
mus bodies related to the jugular bulb (Fig. 15). Its imaging
features match those of glomus tympanicum; in fact, with
large tumours it can become difficult to distinguish the two
entities. Specific imaging signs of glomus jugulare include
widening of the jugular foramen, frequently with evidence
of erosion on CT. Another typical feature of glomus jugu-
lare is erosion of floor of the tympanic cavity, which isunusual for glomus typanicum.34 Clinical symptoms include
impaired hearing with pulsatile tinnitus, vestibular dysfunc-
tion and compromise of cranial nerves within the jugular
foramen, with the glossopharyngeal and vagus nerves being
especially vulnerable to compression.36 Larger glomus jugu-
lare tumours can extend cranially into the hypotympanum
and mimic  glomus tympanicum by being visible on oto-
scopy. Whenever the diagnosis of a glomus tumour is being
queried, it is important to consider vascular mimics, which
could cause catastrophic consequences on biopsy, such as
an ectopic course of the internal carotid artery (ICA), a high
riding internal jugular vein with bone dehiscence or an ICA
aneurysm. Although glomus tumours are relatively common
middle ear lesions, their differential is very wide ranging
from acute inflammation to cholesteatoma and non-glomus
tumours.37
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Fig. 16 – (a) Axial CT demonstrating a lytic-sclerotic
osteosarcoma of the left maxilla (featuring clips relating to
previous surgery) with diffuse infiltration of the ipsilateral
sphenoid base and clivus. (b) Not a tumour: Expansile


















Fig. 17 – (a) and (b) Axial CT and post Gadolinium T1 image
showing typical features of a small glomus tympanicum
tense. Small tumours are often comprised of dense cellularbsence of bone destruction.
.2.2.  Vestibular  aqueduct
he vestibular aqueduct represents a bony canal within the
etrous temporal bone containing the endolymphatic duct,
hich connects the membranous labyrinth of the inner ear
o the posterior temporal endolymphatic sac.
.2.2.1.  Endolymphatic  sac  tumour.  Endolymphatic sac
umour (ELST) is a rare, locally aggressive bone tumour
rising from endolyphatic epithelium in the posterior petrous
emporal bone.38 Invasion of the mastoid, semicircular
anals, cerebellopontine angle and cranial nerves is com-
only present at diagnosis. Proximity to the vestibular
queduct is a key feature of ELST, as these tumours do
ot arise within the aqueduct but at its posterior margin
orresponding to the expected position of the endolymphatic
ac. Among other neoplasms, this tumour frequently occurs
n individuals with von Hippel-Lindau syndrome (Fig. 16).arising on the cochlear promontory (arrow).
6.2.3.  Cerebellopontine  angle
The cerebellopontine (CP) angle represents the junction
between cerebellum and pons, from which the facial (VII) and
vestibulochochlear (VIII) nerves emerge. At a close distance
superiorly, the trigeminal nerve (V) traverses the pontine cis-
tern and can become compressed by large CP angle tumours.
6.2.3.1.  Vestibular  schwannoma.  Vestibular schwannoma (VS)
is the most frequent CP angle neoplasm accounting for 85% of
all CP angle masses and approximately 6–10% of all intracra-
nial tumours.39,40 Most VS lesions are slow-growing with an
estimated progression rate of 1–2 mm/year.41 The classic MRI
morphology is that of an “ice cream on cone” lesion with its
base at the CP angle and its tip (cone) widening the internal
auditory meatus (Fig. 17), small lesions however, may be purely
intracanalicular. VS is often T1 isointense and T2 hyperin-Antoni A regions, which demonstrate avid contrast enhance-
ment. Regions of loosely packed cells, sometimes with cystic
features, are designated Antoni type B and may display
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Fig. 18 – (a) Axial post Gadolinium T1 image demonstrating
a left sided glomus jugulare. (b) Coronal T2 image in a
different patient showing a right sided GJ with flow voids
causing a “salt and pepper” appearance and (c)
corresponding digital subtraction angiogram obtained
during right external carotid artery injection showing
marked hypervascularity of the lesion.
Fig. 19 – Axial T2 image demonstrating a small
endolymphatic sac tumour (arrow) in a patient with
multiple cerebellar lesions representing
haemangioblastomas (arrow heads) and an underlying
diagnosis of von-Hippel Lindau syndrome.
heterogenous enhancement. The distance from the lateral
extent of the intracanalicular lesion component to the fun-
dus of the internal auditory meatus is an important predictor
of hearing outcome and can influence the surgical approach.42
6.2.3.2.  Meningioma.  Meningioma is the second most com-
mon  CP angle tumour and can often be confidently identified,
especially when large. However, in the absence of typical fea-
tures, the distinction from schwannoma can be challenging.
Yamamoto et al.43 recently reported a statistically significant
difference in tumour blood flow using pseudocontinuous arte-
rial spin labelling MRI with higher values demonstrated in
meningioma compared to schwannoma and a potential appli-
cation in patients unable to receive contrast (Figs. 18–20).43
6.2.3.3.  Other  differentials.  Other differentials for a CP angle
mass include an epidermoid cyst, which can be identified
through its characteristic restricted diffusion and lack of con-
trast uptake. Occasionally metastases arise in the internal
auditory meatus. These do not have specific features in the
early stages and may be challenging to diagnose, particularly
if the primary tumour is occult.
6.2.4.  Foramen  magnum
The foramen magnum is an osseous ring formed by the occip-
ital bone and represents the most caudal opening in the skull
base, transmitting the medulla oblongata and the vertebral
arteries. The hypoglossal canal opens into the anterior wall of
the foramen magnum on each side.
6.2.4.1.  Foramen  magnum  tumours.  Tumours at the foramen
magnum fall into the aforementioned categories, mostly
consisting of meningioma, nerve sheath tumours (schwanno-
mas  and neurofibromas) and chordoma.44,45 Lesions confined
to the hypoglossal canal can cause cranial nerve XII
deficit even when small. In contrast, lesions involving the
reports of practical oncology and radio
Fig. 20 – (a) and (b) Axial post Gadolinium T1 and T2

























anterior skull base. Neuroimaging Clin North Amoramen magnum are often of a substantial size before
hey cause symptoms. Clinical symptoms of “foramen mag-
um syndrome” include sensory symptoms such as tingling
n the hands, neck pain and motor deficits progressing to
uadriparesis.45 The surgical resection of foramen magnum
esions is demanding and may benefit from angiographic
maging for operative planning.
.  Conclusion
kull base tumours are a heterogenous group of neoplasms,
ith often overlapping imaging features. Treatment planning
s dependent on excellent imaging, typically provided by the
ombination of thin-section CT and MRI  with multiplanar
eformats to precisely locate the lesion, assess the integrity
f the adjacent structures and suggest an appropriate diag-
osis. An interdisciplinary team approach with an intimate
nderstanding of the clinical, neuroradiological, surgical and
1
therapy 2 1 ( 2 0 1 6 ) 304–318 317
radio-oncological aspects is central to improve the outcome of
these challenging tumours.
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